IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 75.91% | -41.52% | -181.85% | 49.89% | 50.41% |
| Total Depreciation and Amortization | 3.04% | -47.54% | -47.73% | -5.04% | 4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -159.62% | 573.55% | 60.90% | -14.08% | -243.70% |
| Change in Net Operating Assets | -404.06% | -35.80% | 327.85% | -144.08% | 192.26% |
| Cash from Operations | -382.32% | 44.89% | 29.73% | -75.57% | 46.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.24% | -2,130.00% | -112.50% | 2,766.67% | -110.00% |
| Cash from Investing | 102.24% | 3.04% | -387.50% | 2,766.67% | -110.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 66.32% | 99.53% | -1,940.12% |
| Issuance of Common Stock | 2,093.44% | 181.10% | -44.01% | -91.98% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | 1,900.00% | -- | -- | -- |
| Cash from Financing | 1,628.88% | -70.36% | -43.25% | 92.87% | -17.31% |
| Foreign Exchange rate Adjustments | 207.55% | -430.00% | 96.30% | -201.89% | 597.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 300.00% | -- | -- |
| Net Change in Cash | 585.40% | -72.54% | -617.91% | 204.36% | 93.89% |